Clinical trial
Screening of IPSE-Specific Nanobodies and Application in the Diagnosis of Schistosoma Haematobium Infection
NCT07500740 is registered in ClinicalTrials.gov with Pemba Ministry of Health Zanzibar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening of IPSE-Specific Nanobodies and Application in the Diagnosis of Schistosoma Haematobium Infection
- Lead sponsor
- Pemba Ministry of Health Zanzibar
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 1, 2026
- Completion date
- December 1, 2026
- Enrollment
- 2,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.